* 2021 Q3 was low revenue due to the fact that they had to temporarily stop selling one product while they waited for FDA approval. – Analog
This is confusing to me.
Are you saying they were selling a product WITHOUT approval from the FDA… even though they needed it? Or did the FDA come around late and say that a product already for sale needed approval despite previously not needing it?
One choice is alarming with respect to management and the risk profile.
The other choice is just the FDA being late.
Or is there another explanation?
Rob
Former RB and BL Home Fool, Supernova Portfolio Contributor & Maintenance Fool
He is no fool who gives what he cannot keep to gain what he cannot lose.